Reconstitution of Oseltamivir Capsules for Pediatric Use on a Long-Term Cruise: A Treatment Option

Yoshihiro Aoki1, Liliana Del Carmen Amaya Dimas2, Katsuhiko Kitazawa3

  • 1Department of Emergency and Critical Care Medicine, Aizawa Hospital, Nagano, Japan; Department of Pediatrics, Aizawa Hospital, Nagano, Japan.

Insights

Decapsulating oral oseltamivir (Tamiflu) offers a safe method for treating pediatric influenza on cruise ships. This approach ensures correct dosing for children, aiding in early recovery and preventing disease spread during voyages.

Area of Science:

  • Virology
  • Public Health
  • Pediatrics

Background:

  • Influenza poses significant risks for cruise ship passengers, particularly children and the elderly.
  • Cruise ship environments can facilitate rapid transmission of infectious diseases like influenza.
  • Standard oseltamivir capsules are not formulated for appropriate pediatric dosing.

Observation:

  • Two siblings contracted influenza during a world cruise.
  • They were successfully treated with decapsulated oseltamivir, prepared by their mother.
  • The medication was administered orally using a syringe after suspending the powder in water.

Findings:

  • Both pediatric patients recovered fully without complications.
  • The decapsulation method allowed for accurate, age-appropriate dosing.
  • This approach proved effective in a real-world cruise ship scenario.

Implications:

  • Decapsulating oseltamivir is a viable and safe strategy for pediatric influenza treatment in resource-limited environments.
  • This method can help control influenza transmission on cruise voyages.
  • It offers a practical solution for achieving correct pediatric dosing when standard formulations are inadequate.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
543
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.2K